Marian Drug and their Health Benefit

Authors

  • Ms. Abujam Nganthoi Devi
  • Manoj Kumar Mewar University, Gangar, Chittorgarh.
  • Zakarya Noorani Mewar University, Gangar, Chittorgarh.
  • Raikon Teron Mewar University, Gangar, Chittorgarh.
  • Jahan Banoo Mewar University, Gangar, Chittorgarh.
  • Manjeet Singh Mewar University, Gangar, Chittorgarh.

Keywords:

Bacteria, Fungi, Virus, Algae, Sponges, Marine organic compound, Spirulina, Biologic value of protein content

Abstract

Marine drugs are obtained from the marine species of bacteria, virus, algae, fungi, sponges etc. It has consideration on the basis of bioactive metabolites and proposes an exclusive prospect to both enhance the amount of aquatic natural foodstuffs in clinical trials as well as speed up their progress. This review includes some relevant drugs and their uses, classification of moraine organic compound, their drug development and their biotechnologies etc. In developing countries the utilization of algae, particularly Spirulina, as a functional food was suggested decades ago due to the fact that it is not only a protein-dense food source, but because its amino acid profile is considered as of high biologic-value of protein content.

References

1. www.slideshare.net.
2. Vignesh sivanandhan, Raj A, R.Arthur James, Marine Drugs, Implication and future studies article in international Journal of pharmacology, January 2011.
3. Raja A, P, Prabakaran and P. Gajalakshmi, 2010, isolation and screening of antibiotic producing psychrophilic actinomocytes streptococcus sp. Res J Microbiol ,5:44-49.
4. www.slideshere.com, anticancerous drug from marine source.
5. www.mdpi.
6. Drug Discovery from Marine Sources Prof. Dr. Basvaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy ELGAUM-590010 Karnataka, INDIA15th Nov. 2011 Poona College of Pharmacy, BVDU, Pune.
7. www.slideshere.com.merine drug discovery.
8. Lichter W, Lopez DM, Wellham LL, Sigel MM. Ecteinascidia turbinata extracts inhibit DNA synthesis in lymphocytes after mitogenic stimulation by lectins. Proc Soc Exp Biol Med 1975; 150:475478. [PubMed].
9. Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Sun F, Li LH, Martin DG. Ecteinascidins729 743 745 759A 759B and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinate. J Org Chem 1990; 55:45124215.
10. Mendola D, Naranjo L, Santiago A, Duckworth AR, Osinga R. The promise of aquaculture for delivering sustainable supplies of new drugs from the sea: examples from in-sea and tank-based invertebrate culture projects from around the world. Frontiers Mar Biotech 2006:2172.
11. Cuevas C, Pérez M, Martín MJ, Chicharro JL, Fernández- Rivas C, Flores M, Francesch A, Gallego P, Zarzuelo M, de la Calle F, García J, et al. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B Org Lett 2000; 2:25452548. [PubMed].
12. Scotto KW. ET-743: more than an innovative mechanism of action. Anti-Cancer Drugs 2002;13:S3S6. [PubMed].
13. William H.erwick and Amanda M.Fenner, PMC,2014 may.
14. Robert Henrikson,A tex book of Spirulia the world food, seven printing, september 2010.
15. Spirulina:a green factory, ppt slide,Institudeted of biological Research and Biotechnology the national hellenic resource foundatiom, Athens, Greece.
16. Gabriela Gutiérrez-Salmeán, Luis Fabila-Castillo and Germán Chamorro-Cevallos, Nutritional and toxicological aspects of Spirulina (Arthrospira) article, 2015.
17. Pawlik JR. The chemical ecology of sponges on Caribbean reefs: natural products shape natural systems. BioScience 2011;61:888898.

Downloads

Published

2018-10-27

How to Cite

Devi, M. A. N., Kumar, M., Noorani, Z., Teron, R., Banoo, J., & Singh, M. (2018). Marian Drug and their Health Benefit. Journal of Drug Discovery and Development ( ISSN:2581-6861), 2(1), 24-29. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/61

Issue

Vol. 2 No. 1 (2018): Journal of Drug Discovery and Development

Section

Research Article

License

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.